The Mourning Process and Its Importance in Mental Illness: A Psychoanalytic Understanding of Psychiatric Diagnosis and Classification - Dr. Rachel Gibbons (Live)
2024-25 Grand Round Series
Continuing Education information to follow
This event will explore the crucial role of loss and mourning in mental illness bridging psychoanalytic and psychiatric perspectives on mental disorder. Through case vignettes from extensive psychiatric experience we will explore fundamental questions: Why has someone developed a mental illness? What triggered it at this point in their life? How can we understand why it has manifested for them in this particular way? Understanding the important role of loss and mourning in a wide variety of psychiatric disorders provides a basis for engagement with the inner world of patients and thus comprehending different manifestations of distress. Identification of the underlying loss event that underpins the illness can facilitate therapeutic engagement and resolution. The basis for this discussion will be the recent paper "The Mourning Process and its Importance in Mental Illness: a Psychoanalytic understanding of psychiatric diagnosis and classification" in BJPsych Advances (Volume 30 , Issue 2 , March 2024 , pp. 80 - 88 DOI: https://doi.org/10.1192/bja.2023.8).
Dr. Rachel Gibbons has worked in the NHS over the past 20 years in various psychiatric settings as a consultant psychiatrist and consultant medical psychotherapist. She is a psychoanalyst and group analyst and current co-chair of the Patient Safety Group, chair of the Working Group on the Effect of Suicide and Homicide on Psychiatrists, and vice-chair of the Psychotherapy Faculty, at the Royal College of Psychiatrists.
Austen Riggs Center Inc. adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. All those at Austen Riggs Center involved in the planning of this activity, including the presenter(s) listed above, report they have no relevant financial relationships with an ineligible company*.
The views and opinions expressed in this presentation are those of the presenter(s) and do not necessarily represent the official policy or position of the Austen Riggs Center.
* An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, The Austen Riggs Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team